ARIA
发表于 2025-3-28 14:56:38
,Bortezomib in Waldenstrom’s Macroglobulinemia,s. The enthusiastic preclinical and clinical results exerted by bortezomib in multiple myeloma, as well as other hematological malignancies including WM, has validated the idea that the proteasome is an important target in cancer therapy.
荨麻
发表于 2025-3-28 21:17:00
http://reply.papertrans.cn/19/1900/189905/189905_42.png
调味品
发表于 2025-3-29 01:21:58
http://reply.papertrans.cn/19/1900/189905/189905_43.png
虚弱的神经
发表于 2025-3-29 03:36:02
Preclinical Activities of Bortezomib in MM, the Bone Marrow Microenvironment and Pharmacogenomics,ar protein complexes that degrade polyubiquitinated proteins. Bortezomib (Velcade.) is a boronic acid dipeptide that directly binds to enzymatic complex to block chimotrypsin-like activity of proteasome and is the first FDA-approved proteasome inhibitor for multiple myeloma (MM) treatment. Bortezomi
negligence
发表于 2025-3-29 09:13:28
http://reply.papertrans.cn/19/1900/189905/189905_45.png
A保存的
发表于 2025-3-29 15:21:07
http://reply.papertrans.cn/19/1900/189905/189905_46.png
奇思怪想
发表于 2025-3-29 16:57:07
http://reply.papertrans.cn/19/1900/189905/189905_47.png